Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation

Ted V Jacoby; Maria S Asdourian; Nishi Shah; Tracey S Otto; Leah L Thompson; Kerry L Reynolds; Steven T Chen

doi:10.1093/ced/llad180

Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation

Clin Exp Dermatol. 2023 Aug 25;48(9):1058-1060. doi: 10.1093/ced/llad180.

Authors

Ted V Jacoby^{1

2}, Maria S Asdourian^{2

3}, Nishi Shah^{2

4}, Tracey S Otto^{2

5}, Leah L Thompson^{2

3}, Kerry L Reynolds^{3

6}, Steven T Chen^{2

3}

Affiliations

¹ University of Hawaii at Manoa John A. Burns School of Medicine, Honolulu, HI, USA.
² Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
³ Harvard Medical School, Boston, MA, USA.
⁴ Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
⁵ Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
⁶ Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.

PMID: 37171025
DOI: 10.1093/ced/llad180

No abstract available

Publication types

Letter

MeSH terms

Administration, Cutaneous
Humans
Immunotherapy* / adverse effects
Skin*

Grants and funding

Dermatology Foundation